Links
Pages: 1 2 
http://www.cmaj.ca/cgi/content/full/175/1/31-b
This patient had minimal tenderness over his hips, with mild limitation to his range of motion. Both hips had cystic changes in the femoral heads without collapse (Fig. 1). He had been treated 8 months previously with a single intramuscular dose of betamethasone (dose equivalent to 75.5 mg prednisolone) for an allergic condition.
Izge Gunal and Vasfi Karatosun
CMAJ • July 4, 2006; 175 (1).
Review It
Rate It
Bookmark It
http://www.medscape.com/viewarticle/502885
Chronic Osteomyelitis From Staphylococcus Aureus
From Applied Radiology 2005
Douglas R. Lake, MD; Brian Reeves, DO; Allister R. Williams, MD; John Richard McEvoy, Jr.
Summary
A 35-year-old man was transferred from an outside facility for definitive management of long-standing left leg pain. His medical history was unremarkable except for the incision and drainage of an infected left hip 8 years prior (in 1995). Physical examination revealed that the patient was afebrile and had a tender and swollen left knee with a passive range of motion of 10¢ª. Radiographic examination of the left femur prompted magnetic resonance (MR) examination
Sections -
Summary
Diagnosis and Imaging Findings
Discussion
Conclusion
Figures
References
Review It
Rate It
Bookmark It
http://www.medscape.com/viewarticle/408536
Case Report
Four Recurrent Periprosthetic Knee Fractures
from Medscape Orthopaedics & Sports Medicine eJournal[TM] 2001
Arne-Lembit Kööp, MD, Andres Kööp, MD, Irja Kiisküla, MD
Introduction
Periprosthetic fractures of the knee are challenging for the orthopaedist, but recurrent periprosthetic fractures are even more challenging. In this case, a 61-year-old female patient with a diagnosis of gonarthrosis deformans suffered 4 ipsilateral periprosthetic fractures during the 4.5-year period following her primary total-knee arthroplasty.
A detailed case report is presented here and the classification systems, risk factors, and treatment strategies for periprosthetic fractures are discussed.
Review It
Rate It
Bookmark It
http://www.or-live.com/WFUBMC/1558
On April 17, 2007, 5pm EDT, Wake Forest University Baptist Medical Center surgeons will demonstrate a Birmingham Hip™ Resurfacing procedure on www.OR-Live.com. Approved by the Food and Drug Administration in May 2006, the Birmingham Hip Resurfacing System is designed to remove less of the patient’s bone than traditional hip replacement surgery. “This is a breakthrough in total hip surgery that allows hip replacements to be performed in young and active patients and allows them to participate in sports activities without the limitations imposed on standard total joint patients,” said Riyaz Jinnah, M.D., Professor of Orthopaedic Surgery.
Review It
Rate It
Bookmark It
http://www.or-live.com/tgh/1848
A minimally invasive computer assisted, total knee replacement surgery will be performed live over the Internet from Tampa General Hospital on April 18, 2007 at 4 p.m. ET. The procedure involves resurfacing the ends of the bones by making a small incision through which physicians place an implant that prevents bones from rubbing against each other. Because the minimally invasive procedure cuts less or no muscle, it gives the patient the potential for the fastest possible recovery. Kenneth Gustke, M.D., Florida Orthopaedic Institute, founding member of the American Association of Hip and Knee Surgeons, will perform the procedure that will be narrated by Steven Lyons, M.D., a surgeon at the Florida Orthopaedic Institute.
Review It
Rate It
Bookmark It
http://www.medscape.com/viewarticle/452499
Osteonecrosis of the Femoral Head
from Medscape General Medicine™
Posted 05/07/2003
Brett Levine, MS, MD, William Jaffe, MD
Introduction
Osteonecrosis of the femoral head (ONFH) is the end point of a variety of disease processes resulting in decreased blood flow and, ultimately, cellular death within the femoral head.[1] This debilitating disease typically affects younger patients (average age at treatment, 33-38 years old[1,2]) and results in destruction of the hip joint. Between 10,000 and 20,000 new cases of ONFH are diagnosed each year in the United States and treatment costs of these patients is estimated to be more than $1.6 billion.[3] Modern surgical technological advancements have improved outcomes for these patients. However, due to the relatively young age of onset, these patients are often subjected to multiple operative procedures during their lifetime.
Review It
Rate It
Bookmark It
Pages: 1 2 
|